Nanalysis Scientific (CVE:NSCI) Trading Down 7.7% – Time to Sell?

Nanalysis Scientific Corp. (CVE:NSCI)’s stock price traded down 7.7% during mid-day trading on Monday . The company traded as low as C$0.12 and last traded at C$0.12. 133,400 shares traded hands during mid-day trading, an increase of 163% from the average session volume of 50,686 shares. The stock had previously closed at C$0.13.

Nanalysis Scientific Stock Down 7.7%

The company has a debt-to-equity ratio of 71.72, a quick ratio of 1.11 and a current ratio of 1.42. The company has a market cap of C$13.78 million, a PE ratio of -1.20 and a beta of -0.75. The firm has a fifty day simple moving average of C$0.15 and a 200 day simple moving average of C$0.17.

Nanalysis Scientific Company Profile

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries.